Association between serum apolipoprotein B and atrial fibrillation: a case–control study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between serum apolipoprotein B and atrial fibrillation: a case–control study
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-10
DOI
10.1038/s41598-022-13773-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis
- (2022) Shengyi Yang et al. Nutrients
- Risk markers of incident atrial fibrillation in patients with coronary heart disease
- (2021) Maria Tomasdottir et al. AMERICAN HEART JOURNAL
- Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study
- (2021) Qi Jiang et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- No association between alcohol consumption and risk of atrial fibrillation: A two-sample Mendelian randomization study
- (2020) Qi Jiang et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation
- (2020) Sheldon M. Singh et al. Journal of the American Heart Association
- A nonlinear relationship between low-density-lipoprotein cholesterol levels and atrial fibrillation among patients with hypertension in China
- (2020) Jia-Yi Huang et al. Annals of Palliative Medicine
- The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis
- (2020) Oh Young Bang et al. PLoS One
- Atrial fibrillation and stroke
- (2019) Jeff S. Healey et al. CURRENT OPINION IN NEUROLOGY
- Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies
- (2019) Bo Guan et al. Journal of Clinical Lipidology
- Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD])
- (2018) Georgios Mourtzinis et al. AMERICAN JOURNAL OF CARDIOLOGY
- Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease
- (2018) Taiwu Lin et al. ANGIOLOGY
- Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China
- (2018) Xintao Li et al. CLINICAL CARDIOLOGY
- Atrial fibrillation and arterial hypertension
- (2018) M.S Kallistratos et al. PHARMACOLOGICAL RESEARCH
- Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study
- (2018) Zhi-Zhao Li et al. MEDICAL SCIENCE MONITOR
- Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies
- (2018) David S. H. Bell et al. DIABETES OBESITY & METABOLISM
- Autoimmune activation as a determinant of atrial fibrillation among Turks
- (2018) Barış Şimşek et al. MEDICINE
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
- (2017) Hugh Calkins et al. EUROPACE
- Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?
- (2016) Jeffrey W. Meeusen et al. CURRENT OPINION IN LIPIDOLOGY
- Role of Inflammation in Atrial Fibrillation Pathophysiology and Management
- (2015) Masahide Harada et al. CIRCULATION JOURNAL
- Atrial fibrillation in heart failure: what should we do?
- (2015) Dipak Kotecha et al. EUROPEAN HEART JOURNAL
- Apolipoprotein B, the villain in the drama?
- (2015) Qi Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation
- (2015) Alejandra Gutierrez et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Oxidative Stress and Atrial Fibrillation
- (2013) Kai-Chien Yang et al. CIRCULATION
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
- (2013) Sana M. Al-Khatib et al. EUROPEAN HEART JOURNAL
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
- (2012) Moritz F. Sinner et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia
- (2012) Anthony G. Brooks ARCHIVES OF INTERNAL MEDICINE
- Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial Fibrillation
- (2012) Faye L. Lopez et al. Circulation-Arrhythmia and Electrophysiology
- Elevated ApoB serum levels strongly predict early cardiovascular events
- (2012) Bruna Gigante et al. HEART
- Inflammation in Atrial Fibrillation
- (2012) Yutao Guo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevation of liver enzymes within the normal limits and metabolic syndrome
- (2011) Ming-Feng Xia et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET study
- (2010) May Faraj et al. ATHEROSCLEROSIS
- Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review
- (2009) Marianne Benn ATHEROSCLEROSIS
- Relations of Lipid Concentrations to Heart Failure Incidence
- (2009) Raghava S. Velagaleti et al. CIRCULATION
- Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
- (2009) Larry A. Allen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients
- (2009) V.M. van Deursen et al. JOURNAL OF CARDIAC FAILURE
- Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
- (2008) Wolfram Goessling et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started